These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 34336950)

  • 1. Protective Effects of Dexazoxane on Rat Ferroptosis in Doxorubicin-Induced Cardiomyopathy Through Regulating HMGB1.
    Zhang H; Wang Z; Liu Z; Du K; Lu X
    Front Cardiovasc Med; 2021; 8():685434. PubMed ID: 34336950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury.
    Li N; Wang W; Zhou H; Wu Q; Duan M; Liu C; Wu H; Deng W; Shen D; Tang Q
    Free Radic Biol Med; 2020 Nov; 160():303-318. PubMed ID: 32846217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis.
    Yang L; Guan J; Luo S; Yan J; Chen D; Zhang X; Zhong C; Yang P
    Toxicol Appl Pharmacol; 2023 Nov; 479():116713. PubMed ID: 37838222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal thioredoxin-1 from hypoxic human umbilical cord mesenchymal stem cells inhibits ferroptosis in doxorubicin-induced cardiotoxicity via mTORC1 signaling.
    Yu Y; Wu T; Lu Y; Zhao W; Zhang J; Chen Q; Ge G; Hua Y; Chen K; Ullah I; Zhang F
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):108-121. PubMed ID: 36241072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway.
    Chen L; Sun X; Wang Z; Chen M; He Y; Zhang H; Han D; Zheng L
    Toxicol Appl Pharmacol; 2024 Jan; 482():116794. PubMed ID: 38142782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fisetin Attenuates Doxorubicin-Induced Cardiomyopathy
    Li D; Liu X; Pi W; Zhang Y; Yu L; Xu C; Sun Z; Jiang J
    Front Pharmacol; 2021; 12():808480. PubMed ID: 35273493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.
    Wang Y; Ying X; Wang Y; Zou Z; Yuan A; Xiao Z; Geng N; Qiao Z; Li W; Lu X; Pu J
    Cell Signal; 2023 Jul; 107():110655. PubMed ID: 36924813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRDX6 alleviated heart failure by inhibiting doxorubicin-induced ferroptosis through the JAK2/STAT1 pathway inactivation.
    Xiong J; Zhou R; Deng X
    In Vitro Cell Dev Biol Anim; 2024 Apr; 60(4):354-364. PubMed ID: 38530594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF12 restrains mitochondria-dependent ferroptosis in doxorubicin-induced cardiomyocytes through the activation of FGFR1/AMPK/NRF2 signaling.
    Tian G; Li J; Wang W; Zhou L
    Drug Dev Res; 2024 Feb; 85(1):e22149. PubMed ID: 38349269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROS and iron homeostasis dependent ferroptosis play a vital role in 5-Fluorouracil induced cardiotoxicity in vitro and in vivo.
    Li D; Song C; Zhang J; Zhao X
    Toxicology; 2022 Feb; 468():153113. PubMed ID: 35101590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy.
    Huang C; Guo Y; Li T; Sun G; Yang J; Wang Y; Xiang Y; Wang L; Jin M; Li J; Zhou Y; Han B; Huang R; Qiu J; Tan Y; Hu J; Wei Y; Wu B; Mao Y; Lei L; Song X; Li S; Wang Y; Zhang T
    Redox Biol; 2024 Apr; 70():103024. PubMed ID: 38232458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of ENPP2 by FoxO4 protects cardiomyocytes from doxorubicin‑induced toxicity.
    He L; Yang Y; Chen J; Zou P; Li J
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis as a target for protection against cardiomyopathy.
    Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol alleviated 5-FU-induced cardiotoxicity by attenuating GPX4 dependent ferroptosis.
    Li D; Song C; Zhang J; Zhao X
    J Nutr Biochem; 2023 Feb; 112():109241. PubMed ID: 36442718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model.
    Li X; Liang J; Qu L; Liu S; Qin A; Liu H; Wang T; Li W; Zou W
    Chem Biol Interact; 2022 Aug; 363():110008. PubMed ID: 35667395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway.
    Wang Y; Yan S; Liu X; Deng F; Wang P; Yang L; Hu L; Huang K; He J
    Cell Death Differ; 2022 Oct; 29(10):1982-1995. PubMed ID: 35383293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2.
    Wang B; Jin Y; Liu J; Liu Q; Shen Y; Zuo S; Yu Y
    Redox Biol; 2023 Sep; 65():102825. PubMed ID: 37531930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic Nanozymes Suppressed Ferroptosis to Ameliorate Doxorubicin-Induced Cardiotoxicity via Synergetic Effect of Antioxidant Stress and GPX4 Restoration.
    Zhang Y; Liu S; Peng J; Cheng S; Zhang Q; Zhang N; Zhou Z; Zhang Y; Zhao Y; Liu T
    Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression.
    Li Y; Yan J; Zhao Q; Zhang Y; Zhang Y
    Front Pharmacol; 2022; 13():904314. PubMed ID: 36210815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.